查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1192990

患者登记软件市场：按登记类型、软件类型、功能、最终用户分类：2021-2031 年全球机会分析和行业预测

Patient Registry Software Market By Registry type, By Software type, By Functionality, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日期: | 出版商: Allied Market Research | 英文 339 Pages | 商品交期: 2-3个工作天内

价格

2021 年全球患者登记软件市场价值 9.9328 亿美元，预计到 2031 年将达到 25.827 亿美元，2022 年至 2031 年的复合年增长率为 9.7%。

患者登记处使用观察研究方法收集统一数据（临床和其他），并使用规定定义为服务于科学、临床或政策目的的组织系统。 患者登记是出于一个或多个目的收集有关具有相同病症或经历的患者群体的标准化信息。 研究机构、学术临床机构或个人研究团队建立登记处的目的是收集可用于特定研究问题的观察数据。

患者登记软件市场的增长受到以下因素的推动：电子健康记录 (EHR) 使用的增加、慢性病的流行、政府对医疗保健的支持不断增加、老年人口的快速增长以及患者登记在医院和研究机构，大概是受收益增加的驱动。 此外，越来越多地使用存储的数据进行上市后监测，以及政府为建立患者登记而做出的努力也在推动市场的增长。 然而，对数据安全和隐私的担忧以及熟练劳动力的短缺阻碍了市场的增长。 相反，提高技术意识有望为市场创造有利可图的机会。

内容

第一章介绍

第 2 章执行摘要

第 3 章市场概述

  • 市场定义和范围
  • 主要发现
    • 主要投资领域
  • 波特的五力分析
  • 主要公司的定位
  • 市场动态
    • 司机
    • 约束因素
    • 机会
  • COVID-19 影响分析

第 4 章患者註册软件市场：按註册类型

  • 概览
    • 市场规模和预测
  • 按疾病登记
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类
    • 疾病登记和患者登记软件市场：按类型分类
      • 心血管登记市场规模和预测：按地区
      • 糖尿病登记市场规模和预测：按地区
      • 癌症登记市场规模和预测：按地区
      • 稀有登记的市场规模和预测：按地区
      • 其他市场规模和预测：按地区
  • 医疗服务註册
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类
  • 产品註册
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类
    • 产品註册和患者註册软件市场，按类型
      • 医疗器械註册市场规模和预测：按地区
      • 药品註册市场规模的趋势和预测：按地区

第 5 章患者註册软件市场：按软件类型分类

  • 概览
    • 市场规模和预测
  • 独立型
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：国家分析
  • 综合型
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类

第 6 章患者註册软件市场：按功能分类

  • 概览
    • 市场规模和预测
  • 人口健康管理
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类
  • 健康信息交流
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类
  • 患者护理管理
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类
  • 医学研究和临床试验
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类
  • 其他
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类

第 7 章患者註册软件市场：按最终用户分类

  • 概览
    • 市场规模和预测
  • 医院
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类
  • 政府机构、第三方
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类
  • 製药公司、生物技术公司、医疗器械公司
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类
  • 其他
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类

第 8 章患者註册软件市场：按地区

  • 概览
    • 市场规模和预测
  • 北美
    • 主要趋势和机遇
    • 北美市场规模和预测：按註册类型
      • 北美疾病登记和患者登记软件市场：按类型分类
      • 北美产品註册和患者註册软件市场，按类型
    • 北美市场规模和预测：按软件类型
    • 北美市场规模和预测：按功能分类
    • 北美市场规模和预测：按最终用户分类
    • 北美市场规模和预测：按国家/地区分类
      • 美国
      • 加拿大
      • 墨西哥
  • 欧洲
    • 主要趋势和机遇
    • 欧洲市场规模和预测：按註册类型
      • 欧洲疾病登记和患者登记软件市场：按类型分类
      • 欧洲产品註册和患者註册软件市场：按类型分类
    • 欧洲市场规模和预测：按软件类型
    • 欧洲市场规模和预测：按功能分类
    • 欧洲市场规模和预测：按最终用户分类
    • 欧洲市场规模和预测：按国家/地区分类
      • 德国
      • 法国
      • 英国
      • 意大利
      • 西班牙
      • 其他欧洲地区
  • 亚太地区
    • 主要趋势和机遇
    • 亚太市场规模和预测：按註册类型
      • 亚太地区疾病登记和患者登记软件市场：按类型分类
      • 亚太地区产品註册和患者註册软件市场，按类型
    • 亚太市场规模和预测：按软件类型
    • 亚太市场规模和预测：按功能分类
    • 亚太市场规模和预测：按最终用户分类
    • 亚太地区的市场规模和预测：按国家/地区分类
      • 日本
      • 中国
      • 澳大利亚
      • 印度
      • 韩国
      • 其他亚太地区
  • 拉美
    • 主要趋势和机遇
    • LAMEA 市场规模和预测：按註册类型
      • LAMEA 疾病登记和患者登记软件市场：按类型分类
      • LAMEA 产品註册和患者註册软件市场：按类型分类
    • LAMEA 市场规模和预测：按软件类型
    • LAMEA 市场规模和预测：按功能分类
    • LAMEA 市场规模和预测：按最终用户分类
    • LAMEA 市场规模和预测：按国家/地区分类
      • 巴西
      • 沙特阿拉伯
      • 南非
      • 拉美其他地区

第九章商业条件

  • 简介
  • 关键成功策略
  • 10 家主要公司的产品映射
  • 比赛仪表板
  • 竞争热图
  • 主要发展

第十章公司简介

  • Conduent, Inc.
  • Dacima Software Inc.
  • Elekta AB（pub）
  • FIGmd, Inc.
  • IBM Corp
  • ImageTrend, Inc.
  • IQVIA Holdings
  • McKesson Corporation
  • OpenText Corporation
  • Optum, Inc.
  • Ordinal Data, Inc.
  • Premier, Inc.
Product Code: A02490

The global patient registry software market was valued at $993.28 million in 2021, and is projected to reach $2,508.27 million by 2031, registering a CAGR of 9.7% from 2022 to 2031.

Patient registries have been defined as an organized system that uses observational study methods to collect uniform data (clinical and other) to evaluate specified outcomes for a population defined by a particular disease, condition, or exposure, and that serves a predetermined scientific, clinical, or policy purpose. A patient registry is a collection for one or more purposes of standardized information about a group of patients who share a condition or experience. Research institutions, academic clinical institutions, or individual research teams establish a registry system for the purpose of observational data collection that can be used for a specific research agenda.

Growth of the patient registry software market is driven by increase in the usage of electronic health records (EHRs), increase in prevalence of chronic diseases, rise in government support for healthcare, surge in geriatric population and increase in potential benefits of patient registry in  hospitals and research organizations. Furthermore, the increase in usage of the stored data for post-marketing surveillance and surge in government initiatives to build patient registries help increase the growth of the market. However, concerns related to the security and privacy of the data and dearth of skilled resources hinder the market growth. Conversely, increase in awareness regarding technologies is expected to create lucrative opportunities for the market.

The patient registry software market is segmented on the basis of registry type, software type, functionality, end user and region. On the basis of registry type, the market is divided into disease registry, health service registry and product registry. The disease registry segment is further segmented by type into cardiovascular registry, diabetes registry, cancer registry, rare disease registry and others. The product registry segment is further divided into medical device registry and drug registry. On the basis of software type, the market is classified into standalone and integrated. On the basis of functionality, the market is classified into population health management, health information exchange, patient care management, medical research and clinical studies and others. On the basis of end user, the market is classified into hospitals, government and third party organizations, pharma, biotech and medical device companies and others. Region wise, the market is studied across North America, Europe, Asia-Pacific, and LAMEA.

The key market players operating in this market include Allscripts healthcare solutions, Inc., Conduent Inc., Dacima Software Inc., Elekta Solutions AB, ImageTrend, Inc., IQVIA Holdings Inc., McKesson Corporation, MRO Corp. (FIGmd, Inc.), Open Text Corporation, Ordinal data, Inc., Premier, Inc, UnitedHealth Group Inc. (Optum Inc.).

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the patient registry software market analysis from 2021 to 2031 to identify the prevailing patient registry software market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the patient registry software market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global patient registry software market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Registry type

  • Disease Registry
    • Type
    • Cardiovascular Registry
    • Diabetes Registry
    • Cancer Registry
    • Rare Disease Registry
    • Others
  • Health Service Registry
  • Product Registry
    • Type
    • Medical device Registry
    • Drug Registry

By Software type

  • Standalone
  • Integrated

By Functionality

  • Population Health Management
  • Health Information Exchange
  • Patient Care Management
  • Medical Research and Clinical Studies
  • Others

By End User

  • Hospitals
  • Government and third party organizations
  • Pharma, Biotech and Medical Device Companies
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest Of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest Of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest Of LAMEA
  • Key Market Players
    • Conduent, Inc.
    • Dacima Software Inc.
    • Elekta AB (pub)
    • FIGmd, Inc.
    • IBM Corp
    • ImageTrend, Inc.
    • IQVIA Holdings
    • McKesson Corporation
    • OpenText Corporation
    • Optum, Inc.
    • Ordinal Data, Inc.
    • Premier, Inc.

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Disease Registry
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
    • 4.2.4 Disease Registry Patient Registry Software Market by Type
      • 4.2.4.1 Cardiovascular Registry Market size and forecast, by region
      • 4.2.4.2 Diabetes Registry Market size and forecast, by region
      • 4.2.4.3 Cancer Registry Market size and forecast, by region
      • 4.2.4.4 Rare Disease Registry Market size and forecast, by region
      • 4.2.4.5 Others Market size and forecast, by region
  • 4.3 Health Service Registry
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country
  • 4.4 Product Registry
    • 4.4.1 Key market trends, growth factors and opportunities
    • 4.4.2 Market size and forecast, by region
    • 4.4.3 Market analysis by country
    • 4.4.4 Product Registry Patient Registry Software Market by Type
      • 4.4.4.1 Medical device Registry Market size and forecast, by region
      • 4.4.4.2 Drug Registry Market size and forecast, by region

CHAPTER 5: PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Standalone
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
  • 5.3 Integrated
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country

CHAPTER 6: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Population Health Management
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market analysis by country
  • 6.3 Health Information Exchange
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market analysis by country
  • 6.4 Patient Care Management
    • 6.4.1 Key market trends, growth factors and opportunities
    • 6.4.2 Market size and forecast, by region
    • 6.4.3 Market analysis by country
  • 6.5 Medical Research and Clinical Studies
    • 6.5.1 Key market trends, growth factors and opportunities
    • 6.5.2 Market size and forecast, by region
    • 6.5.3 Market analysis by country
  • 6.6 Others
    • 6.6.1 Key market trends, growth factors and opportunities
    • 6.6.2 Market size and forecast, by region
    • 6.6.3 Market analysis by country

CHAPTER 7: PATIENT REGISTRY SOFTWARE MARKET, BY END USER

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 Hospitals
    • 7.2.1 Key market trends, growth factors and opportunities
    • 7.2.2 Market size and forecast, by region
    • 7.2.3 Market analysis by country
  • 7.3 Government and third party organizations
    • 7.3.1 Key market trends, growth factors and opportunities
    • 7.3.2 Market size and forecast, by region
    • 7.3.3 Market analysis by country
  • 7.4 Pharma, Biotech and Medical Device Companies
    • 7.4.1 Key market trends, growth factors and opportunities
    • 7.4.2 Market size and forecast, by region
    • 7.4.3 Market analysis by country
  • 7.5 Others
    • 7.5.1 Key market trends, growth factors and opportunities
    • 7.5.2 Market size and forecast, by region
    • 7.5.3 Market analysis by country

CHAPTER 8: PATIENT REGISTRY SOFTWARE MARKET, BY REGION

  • 8.1 Overview
    • 8.1.1 Market size and forecast
  • 8.2 North America
    • 8.2.1 Key trends and opportunities
    • 8.2.2 North America Market size and forecast, by Registry type
      • 8.2.2.1 North America Disease Registry Patient Registry Software Market by Type
      • 8.2.2.2 North America Product Registry Patient Registry Software Market by Type
    • 8.2.3 North America Market size and forecast, by Software type
    • 8.2.4 North America Market size and forecast, by Functionality
    • 8.2.5 North America Market size and forecast, by End User
    • 8.2.6 North America Market size and forecast, by country
      • 8.2.6.1 U.S.
      • 8.2.6.1.1 Market size and forecast, by Registry type
      • 8.2.6.1.2 Market size and forecast, by Software type
      • 8.2.6.1.3 Market size and forecast, by Functionality
      • 8.2.6.1.4 Market size and forecast, by End User
      • 8.2.6.2 Canada
      • 8.2.6.2.1 Market size and forecast, by Registry type
      • 8.2.6.2.2 Market size and forecast, by Software type
      • 8.2.6.2.3 Market size and forecast, by Functionality
      • 8.2.6.2.4 Market size and forecast, by End User
      • 8.2.6.3 Mexico
      • 8.2.6.3.1 Market size and forecast, by Registry type
      • 8.2.6.3.2 Market size and forecast, by Software type
      • 8.2.6.3.3 Market size and forecast, by Functionality
      • 8.2.6.3.4 Market size and forecast, by End User
  • 8.3 Europe
    • 8.3.1 Key trends and opportunities
    • 8.3.2 Europe Market size and forecast, by Registry type
      • 8.3.2.1 Europe Disease Registry Patient Registry Software Market by Type
      • 8.3.2.2 Europe Product Registry Patient Registry Software Market by Type
    • 8.3.3 Europe Market size and forecast, by Software type
    • 8.3.4 Europe Market size and forecast, by Functionality
    • 8.3.5 Europe Market size and forecast, by End User
    • 8.3.6 Europe Market size and forecast, by country
      • 8.3.6.1 Germany
      • 8.3.6.1.1 Market size and forecast, by Registry type
      • 8.3.6.1.2 Market size and forecast, by Software type
      • 8.3.6.1.3 Market size and forecast, by Functionality
      • 8.3.6.1.4 Market size and forecast, by End User
      • 8.3.6.2 France
      • 8.3.6.2.1 Market size and forecast, by Registry type
      • 8.3.6.2.2 Market size and forecast, by Software type
      • 8.3.6.2.3 Market size and forecast, by Functionality
      • 8.3.6.2.4 Market size and forecast, by End User
      • 8.3.6.3 UK
      • 8.3.6.3.1 Market size and forecast, by Registry type
      • 8.3.6.3.2 Market size and forecast, by Software type
      • 8.3.6.3.3 Market size and forecast, by Functionality
      • 8.3.6.3.4 Market size and forecast, by End User
      • 8.3.6.4 Italy
      • 8.3.6.4.1 Market size and forecast, by Registry type
      • 8.3.6.4.2 Market size and forecast, by Software type
      • 8.3.6.4.3 Market size and forecast, by Functionality
      • 8.3.6.4.4 Market size and forecast, by End User
      • 8.3.6.5 Spain
      • 8.3.6.5.1 Market size and forecast, by Registry type
      • 8.3.6.5.2 Market size and forecast, by Software type
      • 8.3.6.5.3 Market size and forecast, by Functionality
      • 8.3.6.5.4 Market size and forecast, by End User
      • 8.3.6.6 Rest of Europe
      • 8.3.6.6.1 Market size and forecast, by Registry type
      • 8.3.6.6.2 Market size and forecast, by Software type
      • 8.3.6.6.3 Market size and forecast, by Functionality
      • 8.3.6.6.4 Market size and forecast, by End User
  • 8.4 Asia-Pacific
    • 8.4.1 Key trends and opportunities
    • 8.4.2 Asia-Pacific Market size and forecast, by Registry type
      • 8.4.2.1 Asia-Pacific Disease Registry Patient Registry Software Market by Type
      • 8.4.2.2 Asia-Pacific Product Registry Patient Registry Software Market by Type
    • 8.4.3 Asia-Pacific Market size and forecast, by Software type
    • 8.4.4 Asia-Pacific Market size and forecast, by Functionality
    • 8.4.5 Asia-Pacific Market size and forecast, by End User
    • 8.4.6 Asia-Pacific Market size and forecast, by country
      • 8.4.6.1 Japan
      • 8.4.6.1.1 Market size and forecast, by Registry type
      • 8.4.6.1.2 Market size and forecast, by Software type
      • 8.4.6.1.3 Market size and forecast, by Functionality
      • 8.4.6.1.4 Market size and forecast, by End User
      • 8.4.6.2 China
      • 8.4.6.2.1 Market size and forecast, by Registry type
      • 8.4.6.2.2 Market size and forecast, by Software type
      • 8.4.6.2.3 Market size and forecast, by Functionality
      • 8.4.6.2.4 Market size and forecast, by End User
      • 8.4.6.3 Australia
      • 8.4.6.3.1 Market size and forecast, by Registry type
      • 8.4.6.3.2 Market size and forecast, by Software type
      • 8.4.6.3.3 Market size and forecast, by Functionality
      • 8.4.6.3.4 Market size and forecast, by End User
      • 8.4.6.4 India
      • 8.4.6.4.1 Market size and forecast, by Registry type
      • 8.4.6.4.2 Market size and forecast, by Software type
      • 8.4.6.4.3 Market size and forecast, by Functionality
      • 8.4.6.4.4 Market size and forecast, by End User
      • 8.4.6.5 South Korea
      • 8.4.6.5.1 Market size and forecast, by Registry type
      • 8.4.6.5.2 Market size and forecast, by Software type
      • 8.4.6.5.3 Market size and forecast, by Functionality
      • 8.4.6.5.4 Market size and forecast, by End User
      • 8.4.6.6 Rest of Asia-Pacific
      • 8.4.6.6.1 Market size and forecast, by Registry type
      • 8.4.6.6.2 Market size and forecast, by Software type
      • 8.4.6.6.3 Market size and forecast, by Functionality
      • 8.4.6.6.4 Market size and forecast, by End User
  • 8.5 LAMEA
    • 8.5.1 Key trends and opportunities
    • 8.5.2 LAMEA Market size and forecast, by Registry type
      • 8.5.2.1 LAMEA Disease Registry Patient Registry Software Market by Type
      • 8.5.2.2 LAMEA Product Registry Patient Registry Software Market by Type
    • 8.5.3 LAMEA Market size and forecast, by Software type
    • 8.5.4 LAMEA Market size and forecast, by Functionality
    • 8.5.5 LAMEA Market size and forecast, by End User
    • 8.5.6 LAMEA Market size and forecast, by country
      • 8.5.6.1 Brazil
      • 8.5.6.1.1 Market size and forecast, by Registry type
      • 8.5.6.1.2 Market size and forecast, by Software type
      • 8.5.6.1.3 Market size and forecast, by Functionality
      • 8.5.6.1.4 Market size and forecast, by End User
      • 8.5.6.2 Saudi Arabia
      • 8.5.6.2.1 Market size and forecast, by Registry type
      • 8.5.6.2.2 Market size and forecast, by Software type
      • 8.5.6.2.3 Market size and forecast, by Functionality
      • 8.5.6.2.4 Market size and forecast, by End User
      • 8.5.6.3 South Africa
      • 8.5.6.3.1 Market size and forecast, by Registry type
      • 8.5.6.3.2 Market size and forecast, by Software type
      • 8.5.6.3.3 Market size and forecast, by Functionality
      • 8.5.6.3.4 Market size and forecast, by End User
      • 8.5.6.4 Rest of LAMEA
      • 8.5.6.4.1 Market size and forecast, by Registry type
      • 8.5.6.4.2 Market size and forecast, by Software type
      • 8.5.6.4.3 Market size and forecast, by Functionality
      • 8.5.6.4.4 Market size and forecast, by End User

CHAPTER 9: COMPANY LANDSCAPE

  • 9.1. Introduction
  • 9.2. Top winning strategies
  • 9.3. Product Mapping of Top 10 Player
  • 9.4. Competitive Dashboard
  • 9.5. Competitive Heatmap
  • 9.6. Key developments

CHAPTER 10: COMPANY PROFILES

  • 10.1 Conduent, Inc.
    • 10.1.1 Company overview
    • 10.1.2 Company snapshot
    • 10.1.3 Operating business segments
    • 10.1.4 Product portfolio
    • 10.1.5 Business performance
    • 10.1.6 Key strategic moves and developments
  • 10.2 Dacima Software Inc.
    • 10.2.1 Company overview
    • 10.2.2 Company snapshot
    • 10.2.3 Operating business segments
    • 10.2.4 Product portfolio
    • 10.2.5 Business performance
    • 10.2.6 Key strategic moves and developments
  • 10.3 Elekta AB (pub)
    • 10.3.1 Company overview
    • 10.3.2 Company snapshot
    • 10.3.3 Operating business segments
    • 10.3.4 Product portfolio
    • 10.3.5 Business performance
    • 10.3.6 Key strategic moves and developments
  • 10.4 FIGmd, Inc.
    • 10.4.1 Company overview
    • 10.4.2 Company snapshot
    • 10.4.3 Operating business segments
    • 10.4.4 Product portfolio
    • 10.4.5 Business performance
    • 10.4.6 Key strategic moves and developments
  • 10.5 IBM Corp
    • 10.5.1 Company overview
    • 10.5.2 Company snapshot
    • 10.5.3 Operating business segments
    • 10.5.4 Product portfolio
    • 10.5.5 Business performance
    • 10.5.6 Key strategic moves and developments
  • 10.6 ImageTrend, Inc.
    • 10.6.1 Company overview
    • 10.6.2 Company snapshot
    • 10.6.3 Operating business segments
    • 10.6.4 Product portfolio
    • 10.6.5 Business performance
    • 10.6.6 Key strategic moves and developments
  • 10.7 IQVIA Holdings
    • 10.7.1 Company overview
    • 10.7.2 Company snapshot
    • 10.7.3 Operating business segments
    • 10.7.4 Product portfolio
    • 10.7.5 Business performance
    • 10.7.6 Key strategic moves and developments
  • 10.8 McKesson Corporation
    • 10.8.1 Company overview
    • 10.8.2 Company snapshot
    • 10.8.3 Operating business segments
    • 10.8.4 Product portfolio
    • 10.8.5 Business performance
    • 10.8.6 Key strategic moves and developments
  • 10.9 OpenText Corporation
    • 10.9.1 Company overview
    • 10.9.2 Company snapshot
    • 10.9.3 Operating business segments
    • 10.9.4 Product portfolio
    • 10.9.5 Business performance
    • 10.9.6 Key strategic moves and developments
  • 10.10 Optum, Inc.
    • 10.10.1 Company overview
    • 10.10.2 Company snapshot
    • 10.10.3 Operating business segments
    • 10.10.4 Product portfolio
    • 10.10.5 Business performance
    • 10.10.6 Key strategic moves and developments
  • 10.11 Ordinal Data, Inc.
    • 10.11.1 Company overview
    • 10.11.2 Company snapshot
    • 10.11.3 Operating business segments
    • 10.11.4 Product portfolio
    • 10.11.5 Business performance
    • 10.11.6 Key strategic moves and developments
  • 10.12 Premier, Inc.
    • 10.12.1 Company overview
    • 10.12.2 Company snapshot
    • 10.12.3 Operating business segments
    • 10.12.4 Product portfolio
    • 10.12.5 Business performance
    • 10.12.6 Key strategic moves and developments

LIST OF TABLES

  • TABLE 1. GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 2. PATIENT REGISTRY SOFTWARE MARKET, FOR DISEASE REGISTRY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 3. PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRY, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 4. GLOBAL DISEASE REGISTRY PATIENT REGISTRY SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 5. PATIENT REGISTRY SOFTWARE MARKET, FOR CARDIOVASCULAR REGISTRY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 6. PATIENT REGISTRY SOFTWARE MARKET, FOR DIABETES REGISTRY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 7. PATIENT REGISTRY SOFTWARE MARKET, FOR CANCER REGISTRY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 8. PATIENT REGISTRY SOFTWARE MARKET, FOR RARE DISEASE REGISTRY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 9. PATIENT REGISTRY SOFTWARE MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 10. PATIENT REGISTRY SOFTWARE MARKET, FOR HEALTH SERVICE REGISTRY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 11. PATIENT REGISTRY SOFTWARE MARKET FOR HEALTH SERVICE REGISTRY, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 12. PATIENT REGISTRY SOFTWARE MARKET, FOR PRODUCT REGISTRY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 13. PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRY, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 14. GLOBAL PRODUCT REGISTRY PATIENT REGISTRY SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 15. PATIENT REGISTRY SOFTWARE MARKET, FOR MEDICAL DEVICE REGISTRY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 16. PATIENT REGISTRY SOFTWARE MARKET, FOR DRUG REGISTRY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 17. GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 18. PATIENT REGISTRY SOFTWARE MARKET, FOR STANDALONE, BY REGION, 2021-2031 ($MILLION)
  • TABLE 19. PATIENT REGISTRY SOFTWARE MARKET FOR STANDALONE, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 20. PATIENT REGISTRY SOFTWARE MARKET, FOR INTEGRATED, BY REGION, 2021-2031 ($MILLION)
  • TABLE 21. PATIENT REGISTRY SOFTWARE MARKET FOR INTEGRATED, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 22. GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 23. PATIENT REGISTRY SOFTWARE MARKET, FOR POPULATION HEALTH MANAGEMENT, BY REGION, 2021-2031 ($MILLION)
  • TABLE 24. PATIENT REGISTRY SOFTWARE MARKET FOR POPULATION HEALTH MANAGEMENT, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 25. PATIENT REGISTRY SOFTWARE MARKET, FOR HEALTH INFORMATION EXCHANGE, BY REGION, 2021-2031 ($MILLION)
  • TABLE 26. PATIENT REGISTRY SOFTWARE MARKET FOR HEALTH INFORMATION EXCHANGE, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 27. PATIENT REGISTRY SOFTWARE MARKET, FOR PATIENT CARE MANAGEMENT, BY REGION, 2021-2031 ($MILLION)
  • TABLE 28. PATIENT REGISTRY SOFTWARE MARKET FOR PATIENT CARE MANAGEMENT, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 29. PATIENT REGISTRY SOFTWARE MARKET, FOR MEDICAL RESEARCH AND CLINICAL STUDIES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 30. PATIENT REGISTRY SOFTWARE MARKET FOR MEDICAL RESEARCH AND CLINICAL STUDIES, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 31. PATIENT REGISTRY SOFTWARE MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 32. PATIENT REGISTRY SOFTWARE MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 33. GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 34. PATIENT REGISTRY SOFTWARE MARKET, FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 35. PATIENT REGISTRY SOFTWARE MARKET FOR HOSPITALS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 36. PATIENT REGISTRY SOFTWARE MARKET, FOR GOVERNMENT AND THIRD PARTY ORGANIZATIONS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 37. PATIENT REGISTRY SOFTWARE MARKET FOR GOVERNMENT AND THIRD PARTY ORGANIZATIONS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 38. PATIENT REGISTRY SOFTWARE MARKET, FOR PHARMA, BIOTECH AND MEDICAL DEVICE COMPANIES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 39. PATIENT REGISTRY SOFTWARE MARKET FOR PHARMA, BIOTECH AND MEDICAL DEVICE COMPANIES, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 40. PATIENT REGISTRY SOFTWARE MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 41. PATIENT REGISTRY SOFTWARE MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 42. PATIENT REGISTRY SOFTWARE MARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 43. NORTH AMERICA PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 44. NORTH AMERICA DISEASE REGISTRY PATIENT REGISTRY SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 45. NORTH AMERICA PRODUCT REGISTRY PATIENT REGISTRY SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 46. NORTH AMERICA PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 47. NORTH AMERICA PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 48. NORTH AMERICA PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 49. NORTH AMERICA PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 50. U.S. PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 51. U.S. PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 52. U.S. PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 53. U.S. PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 54. CANADA PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 55. CANADA PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 56. CANADA PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 57. CANADA PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 58. MEXICO PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 59. MEXICO PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 60. MEXICO PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 61. MEXICO PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 62. EUROPE PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 63. EUROPE DISEASE REGISTRY PATIENT REGISTRY SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 64. EUROPE PRODUCT REGISTRY PATIENT REGISTRY SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 65. EUROPE PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 66. EUROPE PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 67. EUROPE PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 68. EUROPE PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 69. GERMANY PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 70. GERMANY PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 71. GERMANY PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 72. GERMANY PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 73. FRANCE PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 74. FRANCE PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 75. FRANCE PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 76. FRANCE PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 77. UK PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 78. UK PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 79. UK PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 80. UK PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 81. ITALY PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 82. ITALY PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 83. ITALY PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 84. ITALY PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 85. SPAIN PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 86. SPAIN PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 87. SPAIN PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 88. SPAIN PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 89. REST OF EUROPE PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 90. REST OF EUROPE PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 91. REST OF EUROPE PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 92. REST OF EUROPE PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 93. ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 94. ASIA-PACIFIC DISEASE REGISTRY PATIENT REGISTRY SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 95. ASIA-PACIFIC PRODUCT REGISTRY PATIENT REGISTRY SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 96. ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 97. ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 98. ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 99. ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 100. JAPAN PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 101. JAPAN PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 102. JAPAN PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 103. JAPAN PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 104. CHINA PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 105. CHINA PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 106. CHINA PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 107. CHINA PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 108. AUSTRALIA PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 109. AUSTRALIA PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 110. AUSTRALIA PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 111. AUSTRALIA PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 112. INDIA PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 113. INDIA PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 114. INDIA PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 115. INDIA PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 116. SOUTH KOREA PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 117. SOUTH KOREA PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 118. SOUTH KOREA PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 119. SOUTH KOREA PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 120. REST OF ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 121. REST OF ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 122. REST OF ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 123. REST OF ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 124. LAMEA PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 125. LAMEA DISEASE REGISTRY PATIENT REGISTRY SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 126. LAMEA PRODUCT REGISTRY PATIENT REGISTRY SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 127. LAMEA PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 128. LAMEA PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 129. LAMEA PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 130. LAMEA PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 131. BRAZIL PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 132. BRAZIL PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 133. BRAZIL PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 134. BRAZIL PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 135. SAUDI ARABIA PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 136. SAUDI ARABIA PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 137. SAUDI ARABIA PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 138. SAUDI ARABIA PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 139. SOUTH AFRICA PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 140. SOUTH AFRICA PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 141. SOUTH AFRICA PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 142. SOUTH AFRICA PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 143. REST OF LAMEA PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 144. REST OF LAMEA PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 145. REST OF LAMEA PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 146. REST OF LAMEA PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 147.CONDUENT, INC.: COMPANY SNAPSHOT
  • TABLE 148.CONDUENT, INC.: OPERATING SEGMENTS
  • TABLE 149.CONDUENT, INC.: PRODUCT PORTFOLIO
  • TABLE 150.CONDUENT, INC.: NET SALES,
  • TABLE 151.CONDUENT, INC.: KEY STRATERGIES
  • TABLE 152.DACIMA SOFTWARE INC.: COMPANY SNAPSHOT
  • TABLE 153.DACIMA SOFTWARE INC.: OPERATING SEGMENTS
  • TABLE 154.DACIMA SOFTWARE INC.: PRODUCT PORTFOLIO
  • TABLE 155.DACIMA SOFTWARE INC.: NET SALES,
  • TABLE 156.DACIMA SOFTWARE INC.: KEY STRATERGIES
  • TABLE 157.ELEKTA AB (PUB): COMPANY SNAPSHOT
  • TABLE 158.ELEKTA AB (PUB): OPERATING SEGMENTS
  • TABLE 159.ELEKTA AB (PUB): PRODUCT PORTFOLIO
  • TABLE 160.ELEKTA AB (PUB): NET SALES,
  • TABLE 161.ELEKTA AB (PUB): KEY STRATERGIES
  • TABLE 162.FIGMD, INC.: COMPANY SNAPSHOT
  • TABLE 163.FIGMD, INC.: OPERATING SEGMENTS
  • TABLE 164.FIGMD, INC.: PRODUCT PORTFOLIO
  • TABLE 165.FIGMD, INC.: NET SALES,
  • TABLE 166.FIGMD, INC.: KEY STRATERGIES
  • TABLE 167.IBM CORP: COMPANY SNAPSHOT
  • TABLE 168.IBM CORP: OPERATING SEGMENTS
  • TABLE 169.IBM CORP: PRODUCT PORTFOLIO
  • TABLE 170.IBM CORP: NET SALES,
  • TABLE 171.IBM CORP: KEY STRATERGIES
  • TABLE 172.IMAGETREND, INC.: COMPANY SNAPSHOT
  • TABLE 173.IMAGETREND, INC.: OPERATING SEGMENTS
  • TABLE 174.IMAGETREND, INC.: PRODUCT PORTFOLIO
  • TABLE 175.IMAGETREND, INC.: NET SALES,
  • TABLE 176.IMAGETREND, INC.: KEY STRATERGIES
  • TABLE 177.IQVIA HOLDINGS: COMPANY SNAPSHOT
  • TABLE 178.IQVIA HOLDINGS: OPERATING SEGMENTS
  • TABLE 179.IQVIA HOLDINGS: PRODUCT PORTFOLIO
  • TABLE 180.IQVIA HOLDINGS: NET SALES,
  • TABLE 181.IQVIA HOLDINGS: KEY STRATERGIES
  • TABLE 182.MCKESSON CORPORATION: COMPANY SNAPSHOT
  • TABLE 183.MCKESSON CORPORATION: OPERATING SEGMENTS
  • TABLE 184.MCKESSON CORPORATION: PRODUCT PORTFOLIO
  • TABLE 185.MCKESSON CORPORATION: NET SALES,
  • TABLE 186.MCKESSON CORPORATION: KEY STRATERGIES
  • TABLE 187.OPENTEXT CORPORATION: COMPANY SNAPSHOT
  • TABLE 188.OPENTEXT CORPORATION: OPERATING SEGMENTS
  • TABLE 189.OPENTEXT CORPORATION: PRODUCT PORTFOLIO
  • TABLE 190.OPENTEXT CORPORATION: NET SALES,
  • TABLE 191.OPENTEXT CORPORATION: KEY STRATERGIES
  • TABLE 192.OPTUM, INC.: COMPANY SNAPSHOT
  • TABLE 193.OPTUM, INC.: OPERATING SEGMENTS
  • TABLE 194.OPTUM, INC.: PRODUCT PORTFOLIO
  • TABLE 195.OPTUM, INC.: NET SALES,
  • TABLE 196.OPTUM, INC.: KEY STRATERGIES
  • TABLE 197.ORDINAL DATA, INC.: COMPANY SNAPSHOT
  • TABLE 198.ORDINAL DATA, INC.: OPERATING SEGMENTS
  • TABLE 199.ORDINAL DATA, INC.: PRODUCT PORTFOLIO
  • TABLE 200.ORDINAL DATA, INC.: NET SALES,
  • TABLE 201.ORDINAL DATA, INC.: KEY STRATERGIES
  • TABLE 202.PREMIER, INC.: COMPANY SNAPSHOT
  • TABLE 203.PREMIER, INC.: OPERATING SEGMENTS
  • TABLE 204.PREMIER, INC.: PRODUCT PORTFOLIO
  • TABLE 205.PREMIER, INC.: NET SALES,
  • TABLE 206.PREMIER, INC.: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.PATIENT REGISTRY SOFTWARE MARKET SEGMENTATION
  • FIGURE 2.PATIENT REGISTRY SOFTWARE MARKET,2021-2031
  • FIGURE 3.PATIENT REGISTRY SOFTWARE MARKET,2021-2031
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.PATIENT REGISTRY SOFTWARE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.PATIENT REGISTRY SOFTWARE MARKET,BY REGISTRY TYPE,2021(%)
  • FIGURE 13.COMPARATIVE SHARE ANALYSIS OF DISEASE REGISTRY PATIENT REGISTRY SOFTWARE MARKET,2021-2031(%)
  • FIGURE 14.COMPARATIVE SHARE ANALYSIS OF HEALTH SERVICE REGISTRY PATIENT REGISTRY SOFTWARE MARKET,2021-2031(%)
  • FIGURE 15.COMPARATIVE SHARE ANALYSIS OF PRODUCT REGISTRY PATIENT REGISTRY SOFTWARE MARKET,2021-2031(%)
  • FIGURE 16.PATIENT REGISTRY SOFTWARE MARKET,BY SOFTWARE TYPE,2021(%)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS OF STANDALONE PATIENT REGISTRY SOFTWARE MARKET,2021-2031(%)
  • FIGURE 18.COMPARATIVE SHARE ANALYSIS OF INTEGRATED PATIENT REGISTRY SOFTWARE MARKET,2021-2031(%)
  • FIGURE 19.PATIENT REGISTRY SOFTWARE MARKET,BY FUNCTIONALITY,2021(%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF POPULATION HEALTH MANAGEMENT PATIENT REGISTRY SOFTWARE MARKET,2021-2031(%)
  • FIGURE 21.COMPARATIVE SHARE ANALYSIS OF HEALTH INFORMATION EXCHANGE PATIENT REGISTRY SOFTWARE MARKET,2021-2031(%)
  • FIGURE 22.COMPARATIVE SHARE ANALYSIS OF PATIENT CARE MANAGEMENT PATIENT REGISTRY SOFTWARE MARKET,2021-2031(%)
  • FIGURE 23.COMPARATIVE SHARE ANALYSIS OF MEDICAL RESEARCH AND CLINICAL STUDIES PATIENT REGISTRY SOFTWARE MARKET,2021-2031(%)
  • FIGURE 24.COMPARATIVE SHARE ANALYSIS OF OTHERS PATIENT REGISTRY SOFTWARE MARKET,2021-2031(%)
  • FIGURE 25.PATIENT REGISTRY SOFTWARE MARKET,BY END USER,2021(%)
  • FIGURE 26.COMPARATIVE SHARE ANALYSIS OF HOSPITALS PATIENT REGISTRY SOFTWARE MARKET,2021-2031(%)
  • FIGURE 27.COMPARATIVE SHARE ANALYSIS OF GOVERNMENT AND THIRD PARTY ORGANIZATIONS PATIENT REGISTRY SOFTWARE MARKET,2021-2031(%)
  • FIGURE 28.COMPARATIVE SHARE ANALYSIS OF PHARMA, BIOTECH AND MEDICAL DEVICE COMPANIES PATIENT REGISTRY SOFTWARE MARKET,2021-2031(%)
  • FIGURE 29.COMPARATIVE SHARE ANALYSIS OF OTHERS PATIENT REGISTRY SOFTWARE MARKET,2021-2031(%)
  • FIGURE 30.PATIENT REGISTRY SOFTWARE MARKET BY REGION,2021
  • FIGURE 31.U.S. PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
  • FIGURE 32.CANADA PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
  • FIGURE 33.MEXICO PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
  • FIGURE 34.GERMANY PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
  • FIGURE 35.FRANCE PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
  • FIGURE 36.UK PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
  • FIGURE 37.ITALY PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
  • FIGURE 38.SPAIN PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
  • FIGURE 39.REST OF EUROPE PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
  • FIGURE 40.JAPAN PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
  • FIGURE 41.CHINA PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
  • FIGURE 42.AUSTRALIA PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
  • FIGURE 43.INDIA PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
  • FIGURE 44.SOUTH KOREA PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
  • FIGURE 45.REST OF ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
  • FIGURE 46.BRAZIL PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
  • FIGURE 47.SAUDI ARABIA PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
  • FIGURE 48.SOUTH AFRICA PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
  • FIGURE 49.REST OF LAMEA PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
  • FIGURE 50. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 51. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 52. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 53.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 54.COMPETITIVE DASHBOARD
  • FIGURE 55.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 56.CONDUENT, INC..: NET SALES ,($MILLION)
  • FIGURE 57.DACIMA SOFTWARE INC..: NET SALES ,($MILLION)
  • FIGURE 58.ELEKTA AB (PUB).: NET SALES ,($MILLION)
  • FIGURE 59.FIGMD, INC..: NET SALES ,($MILLION)
  • FIGURE 60.IBM CORP.: NET SALES ,($MILLION)
  • FIGURE 61.IMAGETREND, INC..: NET SALES ,($MILLION)
  • FIGURE 62.IQVIA HOLDINGS.: NET SALES ,($MILLION)
  • FIGURE 63.MCKESSON CORPORATION.: NET SALES ,($MILLION)
  • FIGURE 64.OPENTEXT CORPORATION.: NET SALES ,($MILLION)
  • FIGURE 65.OPTUM, INC..: NET SALES ,($MILLION)
  • FIGURE 66.ORDINAL DATA, INC..: NET SALES ,($MILLION)
  • FIGURE 67.PREMIER, INC..: NET SALES ,($MILLION)